Patient-reported cognitive and psychological screening in neuroendocrine tumors (NETs): A prospective cohort study

#3142

Introduction: An association between neuroendocrine tumors (NET) and neuropsychological symptoms has been suggested, but objective data is limited.

Aim(s): We assessed neuropsychological symptoms in NETs using validated patient-reported outcomes (PRO).

Materials and methods: We prospectively administered the Beck Depression Inventory (BDI-II) and the Functional Assessment of Cancer Treatment Cognitive domain (FACT-Cog), in addition to routine screening with the Edmonton Symptom Assessment System (ESAS), to adults with grade 1-2 NET at a specialized NET clinic (2017-2018). BDI-II and FACT-Cog scores were correlated to ESAS scores with Spearman test.

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author: Hallet J

Authors: Hallet J, Law C, Kazdan J, Zuk V, Singh S,

Keywords: neuroendocrine, patient-reported, cognitive, depression,